Thermo Fisher Scientific Pre-Tax Profit Margin 2010-2022 | TMO
Current and historical pre-tax profit margin for Thermo Fisher Scientific (TMO) from 2010 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Thermo Fisher Scientific pre-tax profit margin for the three months ending December 31, 2022 was .
| Thermo Fisher Scientific Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2022-12-31 |
$44.92B |
$7.84B |
17.44% |
| 2022-09-30 |
$44.17B |
$7.92B |
17.93% |
| 2022-06-30 |
$42.82B |
$8.50B |
19.84% |
| 2022-03-31 |
$41.12B |
$8.63B |
20.98% |
| 2021-12-31 |
$39.21B |
$8.84B |
22.55% |
| 2021-09-30 |
$39.06B |
$9.88B |
25.28% |
| 2021-06-30 |
$38.25B |
$9.95B |
26.02% |
| 2021-03-31 |
$35.89B |
$9.16B |
25.51% |
| 2020-12-31 |
$32.22B |
$7.23B |
22.44% |
| 2020-09-30 |
$28.50B |
$5.37B |
18.85% |
| 2020-06-30 |
$26.25B |
$3.94B |
15.02% |
| 2020-03-31 |
$25.65B |
$4.08B |
15.92% |
| 2019-12-31 |
$25.54B |
$4.07B |
15.94% |
| 2019-09-30 |
$25.22B |
$4.04B |
16.03% |
| 2019-06-30 |
$24.87B |
$4.03B |
16.21% |
| 2019-03-31 |
$24.63B |
$3.45B |
13.99% |
| 2018-12-31 |
$24.36B |
$3.26B |
13.39% |
| 2018-09-30 |
$23.90B |
$3.07B |
12.85% |
| 2018-06-30 |
$23.09B |
$2.74B |
11.86% |
| 2018-03-31 |
$22.01B |
$2.56B |
11.63% |
| 2017-12-31 |
$20.92B |
$2.43B |
11.61% |
| 2017-09-30 |
$19.82B |
$2.26B |
11.41% |
| 2017-06-30 |
$19.20B |
$2.21B |
11.51% |
| 2017-03-31 |
$18.74B |
$2.10B |
11.22% |
| 2016-12-31 |
$18.27B |
$2.02B |
11.08% |
| 2016-09-30 |
$17.97B |
$1.95B |
10.87% |
| 2016-06-30 |
$17.61B |
$1.99B |
11.33% |
| 2016-03-31 |
$17.34B |
$1.98B |
11.40% |
| 2015-12-31 |
$16.97B |
$1.94B |
11.41% |
| 2015-09-30 |
$16.81B |
$1.89B |
11.25% |
| 2015-06-30 |
$16.85B |
$1.96B |
11.64% |
| 2015-03-31 |
$16.91B |
$1.70B |
10.03% |
| 2014-12-31 |
$16.89B |
$2.09B |
12.36% |
| 2014-09-30 |
$15.86B |
$1.93B |
12.15% |
| 2014-06-30 |
$14.89B |
$1.71B |
11.47% |
| 2014-03-31 |
$13.80B |
$1.75B |
12.69% |
| 2013-12-31 |
$13.09B |
$1.32B |
10.08% |
| 2013-09-30 |
$12.88B |
$1.29B |
9.98% |
| 2013-06-30 |
$12.78B |
$1.26B |
9.88% |
| 2013-03-31 |
$12.65B |
$1.30B |
10.29% |
| 2012-12-31 |
$12.51B |
$1.27B |
10.14% |
| 2012-09-30 |
$12.30B |
$1.24B |
10.06% |
| 2012-06-30 |
$12.15B |
$1.21B |
9.94% |
| 2012-03-31 |
$11.90B |
$1.15B |
9.63% |
| 2011-12-31 |
$11.56B |
$1.13B |
9.80% |
| 2011-09-30 |
$11.05B |
$1.10B |
9.95% |
| 2011-06-30 |
$10.75B |
$1.12B |
10.43% |
| 2011-03-31 |
$10.49B |
$1.13B |
10.75% |
| 2010-12-31 |
$10.39B |
$1.09B |
10.47% |
| 2010-09-30 |
$10.49B |
$1.04B |
9.93% |
| 2010-06-30 |
$10.40B |
$1.00B |
9.64% |
| 2010-03-31 |
$10.28B |
$0.97B |
9.46% |
| 2009-12-31 |
$9.91B |
$0.88B |
8.88% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$230.517B |
$44.915B |
|
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
|
